Detalles de la búsqueda
1.
Effect of an obesogenic high-fat and high-sucrose diet on hepatic gene expression signatures in male Collaborative Cross mice.
Am J Physiol Gastrointest Liver Physiol
; 324(3): G232-G243, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625475
2.
Characterization of the variability in the extent of nonalcoholic fatty liver induced by a high-fat diet in the genetically diverse Collaborative Cross mouse model.
FASEB J
; 34(6): 7773-7785, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32304142
3.
Best practices for detection, assessment and management of suspected immune-mediated liver injury caused by immune checkpoint inhibitors during drug development.
J Autoimmun
; 114: 102514, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32768244
4.
Liver safety assessment in clinical trials of new agents for chronic hepatitis B.
J Viral Hepat
; 27(2): 96-109, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31828894
5.
Hepatotoxicity of immune checkpoint inhibitors: An evolving picture of risk associated with a vital class of immunotherapy agents.
Liver Int
; 38(6): 976-987, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-29603856
6.
Liver injury associated with dimethyl fumarate in multiple sclerosis patients.
Mult Scler
; 23(14): 1947-1949, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-28086032
7.
Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States.
Int J Mol Sci
; 17(3): 331, 2016 Mar 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26950122
8.
DILI and drug development: a regulatory perspective.
Semin Liver Dis
; 34(2): 215-26, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24879985
9.
Drug-Induced Liver Injury in the Elderly: Consensus Statements and Recommendations from the IQ-DILI Initiative.
Drug Saf
; 47(4): 301-319, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38217833
10.
Liver biopsy for assessment of suspected drug-induced liver injury in metabolic dysfunction-associated steatohepatitis clinical trials: Expert consensus from the Liver Forum.
Aliment Pharmacol Ther
; 59(2): 201-216, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37877759
11.
Validity of diagnostic codes to identify cases of severe acute liver injury in the US Food and Drug Administration's Mini-Sentinel Distributed Database.
Pharmacoepidemiol Drug Saf
; 22(8): 861-72, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23801638
12.
Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of Collaborative Cross mice fed an obesogenic high-fat and high-sucrose diet.
Epigenetics
; 17(11): 1462-1476, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35324388
13.
Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice.
J Nutr Biochem
; 109: 109108, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35858665
14.
Deciphering the Dynamic Complexities of the Liver Microenvironment - Toward a Better Understanding of Immune-Mediated liver Injury Caused by Immune Checkpoint Inhibitors (ILICI).
AAPS J
; 23(5): 99, 2021 08 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34401948
15.
Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.
Drug Saf
; 44(2): 133-165, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-33141341
16.
An Evaluation of Postmarketing Reports of Serious Idiosyncratic Liver Injury Associated with Ulipristal Acetate for the Treatment of Uterine Fibroids.
Drug Saf
; 43(12): 1267-1276, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32647996
17.
Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.
Aliment Pharmacol Ther
; 51(1): 90-109, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31762074
18.
Next-Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development.
Clin Pharmacol Ther
; 107(2): 333-346, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31314926
19.
Using controlled clinical trials to learn more about acute drug-induced liver injury.
Hepatology
; 48(5): 1680-9, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18853438
20.
Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.
Aliment Pharmacol Ther
; 49(6): 702-713, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30761572